下一个

自动播放

The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma

2 意见 • 07/18/23
分享
嵌入
administrator
administrator
订户
0

Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) and its long-term potential in the field of sarcoma.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放